Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
or

Glaukos Corp (GKOS)

Glaukos Corp (GKOS)
39.37 x 1 139.80 x 1
Pre-market by (Cboe BZX)
97.09 -1.33 (-1.35%) 04/01/25 [NYSE]
39.37 x 1 139.80 x 1
Pre-market 97.09 unch (unch) 19:00 ET
Quote Overview for Tue, Apr 1st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
94.25
Day High
98.39
Open 98.06
Previous Close 98.42 98.42
Volume 908,000 908,000
Avg Vol 978,685 978,685
Stochastic %K 28.85% 28.85%
Weighted Alpha -17.97 -17.97
5-Day Change -9.82 (-9.19%) -9.82 (-9.19%)
52-Week Range 88.16 - 163.71 88.16 - 163.71
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,567,325
  • Shares Outstanding, K 56,567
  • Annual Sales, $ 383,480 K
  • Annual Income, $ -146,370 K
  • EBIT $ -122 M
  • EBITDA $ -86 M
  • 60-Month Beta 0.99
  • Price/Sales 15.05
  • Price/Cash Flow N/A
  • Price/Book 7.33

Options Overview Details

View History
  • Implied Volatility 62.38% ( +3.99%)
  • Historical Volatility 85.49%
  • IV Percentile 85%
  • IV Rank 58.27%
  • IV High 84.37% on 11/01/24
  • IV Low 31.68% on 08/27/24
  • Put/Call Vol Ratio 21.53
  • Today's Volume 676
  • Volume Avg (30-Day) 677
  • Put/Call OI Ratio 1.46
  • Today's Open Interest 7,553
  • Open Int (30-Day) 9,495

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.33
  • Number of Estimates 9
  • High Estimate -0.26
  • Low Estimate -0.39
  • Prior Year -0.70
  • Growth Rate Est. (year over year) +52.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
91.78 +5.79%
on 03/10/25
Period Open: 120.02
120.22 -19.24%
on 03/03/25
-22.93 (-19.11%)
since 02/28/25
3-Month
91.78 +5.79%
on 03/10/25
Period Open: 149.94
163.71 -40.69%
on 01/23/25
-52.85 (-35.25%)
since 12/31/24
52-Week
88.16 +10.13%
on 04/02/24
Period Open: 93.10
163.71 -40.69%
on 01/23/25
+3.99 (+4.29%)
since 04/01/24

Most Recent Stories

More News
GKOS Stock Falls Despite Q4 Earnings & Revenue Beat, Margins Decline

Glaukos Corporation GKOS reported fourth-quarter 2024 adjusted loss of 40 cents per share, narrower than the Zacks Consensus Estimate of a loss of 43 cents. The figure also improved from the year-ago...

AVAH : 5.46 (+0.74%)
MASI : 167.61 (+0.61%)
GKOS : 97.09 (-1.35%)
ATEC : 10.08 (-0.59%)
Glaukos: Q4 Earnings Snapshot

Glaukos: Q4 Earnings Snapshot

GKOS : 97.09 (-1.35%)
What to Expect From These 3 MedTech Stocks This Earnings Season?

As the fourth-quarter earnings season progresses, this week will be crucial for many companies in the medical device sector. According to the latest Earnings Preview report, the Medical sector is poised...

AMN : 23.80 (-2.70%)
ITGR : 118.56 (+0.47%)
GKOS : 97.09 (-1.35%)
Insider Sale: Director at $GKOS (GKOS) Sells 2,000 Shares

Gilbert H Kliman, a director at $GKOS ($GKOS), sold 2,000 shares of the company on 12-11-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 5.8% of their shares....

GKOS : 97.09 (-1.35%)
Here's Why You Should Add Glaukos Stock to Your Portfolio Now

Glaukos Corporation GKOS is well-poised for growth on the back of favorable clinical trial results and a robust product pipeline. However, stiff competition is a concern.Shares of this Zacks Rank #2 (Buy)...

AXGN : 17.81 (-3.73%)
ARAY : 1.7800 (-0.56%)
MASI : 167.61 (+0.61%)
GKOS : 97.09 (-1.35%)
Glaukos: Q3 Earnings Snapshot

Glaukos: Q3 Earnings Snapshot

GKOS : 97.09 (-1.35%)
Glaukos: Q2 Earnings Snapshot

Glaukos: Q2 Earnings Snapshot

GKOS : 97.09 (-1.35%)
Stocks Climb on Strength in Chips Stocks and Fed Rate Cut Optimism

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.61%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.60%. US stock indexes this morning...

$SPX : 5,633.07 (+0.38%)
SPY : 560.97 (+0.28%)
$DOWI : 41,989.96 (-0.03%)
DIA : 419.59 (-0.07%)
$IUXX : 19,436.42 (+0.82%)
QQQ : 472.70 (+0.81%)
ZNM25 : 111-220 (-0.08%)
MU : 88.71 (+2.09%)
NVDA : 110.15 (+1.63%)
AMD : 102.78 (+0.04%)
GFS : 35.98 (-2.52%)
KLAC : 682.46 (+0.39%)
Stocks Push Higher on Fed Rate Cut Optimism

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.54%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.42%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.51%. US stock indexes this morning...

$SPX : 5,633.07 (+0.38%)
SPY : 560.97 (+0.28%)
$DOWI : 41,989.96 (-0.03%)
DIA : 419.59 (-0.07%)
$IUXX : 19,436.42 (+0.82%)
QQQ : 472.70 (+0.81%)
ZNM25 : 111-220 (-0.08%)
PARA : 11.73 (-1.92%)
MU : 88.71 (+2.09%)
IR : 80.61 (+0.72%)
FRPT : 84.47 (+1.56%)
PRFT : 75.96 (+0.64%)
Glaukos: Q1 Earnings Snapshot

Glaukos: Q1 Earnings Snapshot

GKOS : 97.09 (-1.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an...

See More

Key Turning Points

3rd Resistance Point 103.04
2nd Resistance Point 100.72
1st Resistance Point 98.90
Last Price 97.09
1st Support Level 94.76
2nd Support Level 92.44
3rd Support Level 90.62

See More

52-Week High 163.71
Fibonacci 61.8% 134.85
Fibonacci 50% 125.94
Fibonacci 38.2% 117.02
Last Price 97.09
52-Week Low 88.16

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies